Health Industry

"Health Industry" Main

Latest Morning Briefing Stories

Opioid Operators: How Surgeons Ply Patients With Painkillers

KFF Health News Original

Even as awareness of the opioid crisis grew, prescribing habits of surgeons changed very little from 2011 to 2016, found a data analysis by KHN and Johns Hopkins Bloomberg School of Public Health. Use this interactive tool to search by doctor or practicing hospital.

Sen. Alexander Details His Plan To Fix Surprise Medical Bills

KFF Health News Original

A legislative package from Sens. Lamar Alexander (R-Tenn.) and Patty Murray (D-Wash.) would handle surprise medical bills by having insurers pay them the “median in-network rate,” meaning the rate would be similar to what the plan charges other doctors in the area for the same procedure.

Senators Agree Surprise Medical Bills Must Go. But How?

KFF Health News Original

The Senate Health, Education, Labor and Pensions Committee is scheduled next week to mark up a massive legislative package on curbing health costs, but some of the details remain unresolved, including what formula to use to pay doctors and hospitals involved in surprise medical bills.

Miracle Machine Makes Heroic Rescues — And Leaves Patients In Limbo

KFF Health News Original

The use of ECMO, the most aggressive form of life support in modern medicine, has skyrocketed — but along with miraculous rescues, it can leave patients in limbo, kept alive with machines but with no prospect of survival outside the ICU.

In Combating Surprise Bills, Lawmakers Miss Sky-High Air Ambulance Costs

KFF Health News Original

The median cost of an air ambulance bill is more than $36,000 and seldom covered by insurance, sparking many consumer complaints. Yet none of the proposals introduced or circulating in Congress to fix surprise medical bills address these services.

FDA Overlooked Red Flags In Drugmaker’s Testing of New Depression Medicine

KFF Health News Original

In March, a chemical cousin of the anesthetic and club drug ketamine was approved for the treatment of patients with intractable depression. But critics say studies presented to the FDA provided at best modest evidence it worked and did not include information about the safety of the drug, Spravato, for long-term use.

FAQ: How Does New Trump Fetal Tissue Policy Impact Medical Research?

KFF Health News Original

The scientific use of tissue from aborted fetuses has frequently been a hot point of contention between anti-abortion forces and researchers. It heats up again as federal officials announced this week they were ending NIH research using the tissue.

KHN’s ‘What The Health?’: Fetal Tissue Research Is Latest Flashpoint In Abortion Debate

KFF Health News Original

Margot Sanger-Katz of The New York Times, Joanne Kenen of Politico and Paige Winfield Cunningham of The Washington Post join KHN’s Julie Rovner to discuss the Trump administration’s efforts to curtail federally funded research using fetal tissue, the backlash from former Vice President Joe Biden’s support for the anti-abortion Hyde Amendment and how health policy intersects with both trade and immigration policy.

Illinois Clamps Down On Nursing Homes In Wake Of KHN-Chicago Tribune Investigation

KFF Health News Original

In reaction to an investigation by Kaiser Health News and the Chicago Tribune, the Illinois legislature has passed a new law to impose fines on nursing homes that fail to meet minimum staffing requirements.

Watch: A Status Update On Efforts To Address Surprise Medical Bills

KFF Health News Original

KHN correspondent Rachel Bluth appeared on “PBS NewsHour Weekend” to talk with host Megan Thompson about the continuing problem of surprise medical bills and how the issue is playing on Capitol Hill.